UBS O'Connor’s Seagen Inc. Common Stock SGEN Stock Holding History

UBS O'Connor’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,750,496	Closed	-$371M	–	644
2023 Q3	$371M	Sell	1,750,496 -98,609	-5%	-$19.7M	6.61%	3
2023 Q2	$356M	Buy	1,849,105 +1,272,676	+221%	+$253M	7.5%	2
2023 Q1	$116M	Buy	576,429 +572,868	+16,087%	+$91.9M	2.76%	7
2022 Q4	$458K	Sell	3,561 -1,439	-29%	-$186K	0.01%	625
2022 Q3	$684K	Buy	+5,000	New	+$815K	0.01%	780

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

UBS O'Connor's SGEN Position: Q4 2023 in Review

UBS O'Connor sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,750,496 shares — an estimated $371M sold.

UBS O'Connor first reported a position in SGEN in Q3 2022 and held it in 5 quarters. The position peaked at $371M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

UBS O'Connor reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
UBS O'Connor sold 1,750,496 Seagen Inc. Common Stock shares in Q4 2023, an estimated $371M.
UBS O'Connor first reported a position in Seagen Inc. Common Stock in Q3 2022 and held it in 5 quarters.
UBS O'Connor's Seagen Inc. Common Stock position peaked at $371M in Q3 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.